Nanotechnology: A Way for Active Targeting of Cancer Cells

Since cancer is one of the top causes of death, researchers have been working hard for cancer management. Creating drugs that can be utilized for both early detection and efficient treatment, is one of the most challenging parts of cancer treatment. Traditional cancer treatment is linked with a high risk of serious chemotherapeutic side effects and occasionally lacks precise technology for early tumour identification. It was thought that a medication that could serve as a "magic bullet" and could only recognize cancer cells, was required for better therapeutic ratio, defined as the distinction between how treatment impacts cancer cells against healthy tissues. Nanoparticle systems provide numerous potentially efficient approaches for developing customized cancer detection and treatment medications. There are two methods for targeting nanoparticles: passive targeting and active targeting. Nanoparticles can be effectively localized inside the tumour microenvironment with passive targeting. Due to their active targeting, nanoparticles can be actively taken up by tumour cells.

Authors

Publication Details

Journal
Research Journal of Biotechnology
Published
2024-12-31
DOI
https://doi.org/10.25303/202rjbt2220227
Citations
2
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nanotechnology: A Way for Active Targeting of Cancer Cells

Rama Sharma
2 citations
Research Journal of Biotechnology
Nanoparticle-Based Drug Delivery
0.35
article

Nanotechnology: A Way for Active Targeting of Cancer Cells

Rama Sharma
article en
2 citations

Abstract

Since cancer is one of the top causes of death, researchers have been working hard for cancer management. Creating drugs that can be utilized for both early detection and efficient treatment, is one of the most challenging parts of cancer treatment. Traditional cancer treatment is linked with a high risk of serious chemotherapeutic side effects and occasionally lacks precise technology for early tumour identification. It was thought that a medication that could serve as a "magic bullet" and could only recognize cancer cells, was required for better therapeutic ratio, defined as the distinction between how treatment impacts cancer cells against healthy tissues. Nanoparticle systems provide numerous potentially efficient approaches for developing customized cancer detection and treatment medications. There are two methods for targeting nanoparticles: passive targeting and active targeting. Nanoparticles can be effectively localized inside the tumour microenvironment with passive targeting. Due to their active targeting, nanoparticles can be actively taken up by tumour cells.

Research Journal of BiotechnologyVol. 20(2)
Openalex Percentile: Top 42%
Nanoparticle-Based Drug Delivery
0.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nanotechnology: A Way for Active Targeting of Cancer Cells — Rama Sharma · Research Journal of Biotechnology (2024) | TGRS Research Map | TGRS